Corporations are designing next-generation antibodies modeled on these taken from abnormal participants whose immune systems can neutralize any COVID-19 variant—and associated coronaviruses, too. The US…
Corporations are designing next-generation antibodies modeled on these taken from abnormal participants whose immune systems can neutralize any COVID-19 variant—and associated coronaviruses, too. The US…